Tirzepatide: form, reconstitution and lab handling

Physical form and specification

Tirzepatide ships as a white lyophilized (freeze-dried) powder in a sealed glass vial, packaged at 30 mg and 120 mg per vial, ≥99% purity by HPLC. It is a 39-residue synthetic peptide carrying a C20 fatty-diacid chain; that chain makes the molecule amphiphilic and surface-active, which directly shapes how it behaves in solution.

Reconstitution chemistry

The lyophilizate dissolves readily in aqueous buffer. Bacteriostatic water (0.9% benzyl alcohol) is the common reconstitution solvent for research stocks because the benzyl alcohol limits microbial growth in a multi-draw vial. Introduce the diluent slowly down the vial wall rather than jetting it onto the powder cake: the fatty-acid tail makes tirzepatide prone to foaming, and foam denatures peptide at the air-water interface. Swirl gently; do not vortex or shake. The peptide typically clears into a colorless solution within a minute or two. Concentration is set by the diluent volume (mass in the vial ÷ mL added). If a study needs a preservative-free matrix, sterile water or a defined buffer can be substituted, at the cost of no bacteriostatic protection.

Storage and stability

The sealed lyophilized vial is the stable form: store at -20 °C protected from light and moisture; the dry powder tolerates months to years. Brief temperature excursions in transit are tolerated because the freeze-dried state is inherently stable. Once reconstituted, tirzepatide is a solution and its clock starts: keep it at 2-8 °C, use within a few weeks, and avoid repeated freeze-thaw, which shears peptide bonds and promotes aggregation. For longer holds of a reconstituted stock, dispense single-use aliquots frozen at -20 °C or below. Discard any solution that turns cloudy or shows particulates.

Lab handling

Let a cold vial equilibrate to room temperature before opening to avoid condensation onto the powder. Where possible use low-protein-binding tips and tubes, since surface-active peptides adsorb to plastic and glass and can quietly lower the working concentration. Record the lot number and reconstitution date on the vial.

Research context

Tirzepatide is a dual agonist of the GIP and GLP-1 receptors, the reference "twincretin" scaffold. It is widely used in vitro and in animal models to probe incretin-receptor signaling, receptor-bias and cAMP assays, β-cell and adipocyte studies, and comparative pharmacology against single GLP-1 agonists. The extended half-life conferred by albumin binding via the fatty-acid chain also makes it a model compound for studying lipidation-based half-life engineering.